Anzeige
Mehr »
Login
Mittwoch, 19.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
Dominiert dieses Medizin-KI-Unternehmen bald den Gesundheitsmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWS | ISIN: CA27966L3065 | Ticker-Symbol: RBT
Tradegate
18.02.25
11:57 Uhr
2,220 Euro
-0,400
-15,27 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EDESA BIOTECH INC Chart 1 Jahr
5-Tage-Chart
EDESA BIOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,3402,44018.02.

Aktuelle News zur EDESA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrEdesa Biotech, Inc.: Edesa Biotech Reports Fiscal 1st Quarter 2025 Results100TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases...
► Artikel lesen
FrEdesa Biotech, Inc. - 10-Q, Quarterly Report-
DoEdesa Biotech shares jump on $15M private placement 29
DoEdesa Biotech announces $15 million private placement11
DoPre-market Movers: Edesa Biotech, The Trade Desk, Aspen Aerogels, AppLovin, Dutch Bros.342OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.05 A.M. ET).In the Green Edesa Biotech, Inc. (EDSA) is up over 74% at $3.25. AppLovin...
► Artikel lesen
DoEdesa Biotech, Inc.: Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules11
DoEdesa Biotech, Inc. - 8-K, Current Report2
EDESA BIOTECH Aktie jetzt für 0€ handeln
20.12.24Edesa Biotech, Inc. - 10-K/A, Annual Report2
13.12.24Edesa Biotech GAAP EPS of -$1.93 beats by $0.223
13.12.24Edesa Biotech, Inc.: Edesa Biotech Reports Fiscal Year 2024 Results128TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases...
► Artikel lesen
13.12.24Edesa Biotech, Inc. - 10-K, Annual Report-
13.12.24Edesa Biotech, Inc. - 8-K, Current Report-
06.12.24Edesa Biotech-Aktie erreicht 52-Wochen-Tief bei 2,02 US-Dollar1
31.10.24Edesa Leaps as CEO Boosts Holdings1
31.10.24Edesa Biotech CEO invests $5 million in company3
31.10.24Edesa Biotech, Inc. - 8-K, Current Report1
31.10.24Edesa Biotech, Inc.: Edesa Biotech's Founder Makes Strategic Investment in the Company3
04.10.24Edesa Biotech, Inc. - 8-K, Current Report1
09.08.24Edesa Biotech, Inc.: Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results245TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases...
► Artikel lesen
24.06.24BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS301This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acute respiratory distress syndrome (ARDS) due to a variety of causes.This BARDA-funded project is expected...
► Artikel lesen
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1